Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2025-12-25 @ 7:09 PM
NCT ID:
NCT04745832
Group ID:
EG000
Title:
Rituximab Plus Zandelisib
Description:
Rituximab plus Zandelisib for 6 cycles followed by Zandelisib for 20 cycles Zandelisib: Zandelisib 60 mg capsules taken daily for two cycles followed by intermittent schedule starting at Cycle 3 Rituximab: Rituximab IV 375 mg/m2 for 6 cycles
In the Rituximab plus Zandelisib arm, 41 subjects enrolled
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
41
Other Number Affected:
38
Other Number At Risk:
41
Study:
NCT04745832
Results Section:
NCT04745832
Adverse Events Module:
NCT04745832